Acadia Pharmaceuticals | ACAD - Revenu Net





Revenu Net Changement Date
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
ALKERMES USD 501K 66.98M 2026-06
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Cara Therapeutics USD -6.8M 1.28M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Cytokinetics USD -198.76M 7.27M 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Incyte USD 585.6M 282.27M 2026-06
J&J USD 210M 5.32B 2026-09
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Pfizer USD -248M 2.94B 2026-06
Prothena USD 32.72M 54.31M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06